278 related articles for article (PubMed ID: 36747202)
1. Smart nanoparticles and microbeads for interventional embolization therapy of liver cancer: state of the art.
Wu S; Fan K; Yang Q; Chen Z; Hou Y; Zou Y; Cai W; Kang L
J Nanobiotechnology; 2023 Feb; 21(1):42. PubMed ID: 36747202
[TBL] [Abstract][Full Text] [Related]
2. Short-term efficacy and safety of callispheres drug-loaded microsphere embolization in primary hepatocellular carcinoma.
Li J; Wang N; Shi C; Liu Q; Song J; Ye X
J Cancer Res Ther; 2021 Jul; 17(3):733-739. PubMed ID: 34269307
[TBL] [Abstract][Full Text] [Related]
3. Idarubicin-loaded biodegradable microspheres enhance sensitivity to anti-PD1 immunotherapy in transcatheter arterial chemoembolization of hepatocellular carcinoma.
Zheng Z; Ma M; Han X; Li X; Huang J; Zhao Y; Liu H; Kang J; Kong X; Sun G; Sun G; Kong J; Tang W; Shao G; Xiong F; Song J
Acta Biomater; 2023 Feb; 157():337-351. PubMed ID: 36509402
[TBL] [Abstract][Full Text] [Related]
4. Transcatheter arterial chemoembolization with doxorubicin-eluting superabsorbent polymer microspheres in the treatment of hepatocellular carcinoma: midterm follow-up.
Dekervel J; van Malenstein H; Vandecaveye V; Nevens F; van Pelt J; Heye S; Laleman W; Van Steenbergen W; Vaninbroukx J; Verslype C; Maleux G
J Vasc Interv Radiol; 2014 Feb; 25(2):248-55.e1. PubMed ID: 24295569
[TBL] [Abstract][Full Text] [Related]
5. Update on Transarterial Chemoembolization with Drug-Eluting Microspheres for Hepatocellular Carcinoma.
Nouri YM; Kim JH; Yoon HK; Ko HK; Shin JH; Gwon DI
Korean J Radiol; 2019 Jan; 20(1):34-49. PubMed ID: 30627020
[TBL] [Abstract][Full Text] [Related]
6. Multifunctional microbeads for drug delivery in TACE.
Bannerman D; Wan W
Expert Opin Drug Deliv; 2016 Sep; 13(9):1289-300. PubMed ID: 27223469
[TBL] [Abstract][Full Text] [Related]
7. Treatment of hepatocellular carcinoma using arterial chemoembolization with degradable starch microspheres and continuous arterial infusion of 5-fluorouracil.
Ishida K; Hirooka M; Hiraoka A; Kumagi T; Uehara T; Hiasa Y; Horiike N; Onji M
Jpn J Clin Oncol; 2008 Sep; 38(9):596-603. PubMed ID: 18772170
[TBL] [Abstract][Full Text] [Related]
8. Degradable starch microspheres versus ethiodol and doxorubicin in transarterial chemoembolization of hepatocellular carcinoma.
Niessen C; Unterpaintner E; Goessmann H; Schlitt HJ; Mueller-Schilling M; Wohlgemuth WA; Stroszczynski C; Wiggermann P
J Vasc Interv Radiol; 2014 Feb; 25(2):240-7. PubMed ID: 24291001
[TBL] [Abstract][Full Text] [Related]
9. Liver chemoembolization of hepatocellular carcinoma using TANDEM
Delicque J; Guiu B; Boulin M; Schwanz H; Piron L; Cassinotto C
Future Oncol; 2018 Nov; 14(26):2761-2772. PubMed ID: 29953255
[TBL] [Abstract][Full Text] [Related]
10. Biodegradable Microspheres for Transarterial Chemoembolization in Malignant Liver Disease.
Moschovaki-Zeiger O; Arkoudis NA; Giannakis A; Grigoriadis S; Anagnostopoulos F; Spiliopoulos S
Medicina (Kaunas); 2024 Apr; 60(4):. PubMed ID: 38674324
[TBL] [Abstract][Full Text] [Related]
11. Multifunctional nanoplatforms application in the transcatheter chemoembolization against hepatocellular carcinoma.
Yuan G; Liu Z; Wang W; Liu M; Xu Y; Hu W; Fan Y; Zhang X; Liu Y; Si G
J Nanobiotechnology; 2023 Feb; 21(1):68. PubMed ID: 36849981
[TBL] [Abstract][Full Text] [Related]
12. Degradable starch microspheres transarterial chemoembolization (DSMs-TACE) in patients with unresectable hepatocellular carcinoma (HCC): long-term results from a single-center 137-patient cohort prospective study.
Orlacchio A; Chegai F; Roma S; Merolla S; Bosa A; Francioso S
Radiol Med; 2020 Jan; 125(1):98-106. PubMed ID: 31583558
[TBL] [Abstract][Full Text] [Related]
13. Transarterial radioembolization versus chemoembolization for the treatment of hepatocellular carcinoma (TRACE): study protocol for a randomized controlled trial.
Seinstra BA; Defreyne L; Lambert B; Lam MG; Verkooijen HM; van Erpecum KJ; van Hoek B; van Erkel AR; Coenraad MJ; Al Younis I; van Vlierberghe H; van den Bosch MA
Trials; 2012 Aug; 13():144. PubMed ID: 22913492
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the Efficacy of Two Microsphere Embolic Agents for Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma Patients.
Lee SH; Lin CY; Hsu YC; Liu YS; Chuang MT; Ou MC
Cancer Res Treat; 2020 Jan; 52(1):24-30. PubMed ID: 31048665
[TBL] [Abstract][Full Text] [Related]
15. Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma.
Abdel-Rahman OM; Elsayed Z
Cochrane Database Syst Rev; 2016 Feb; 2():CD011313. PubMed ID: 26905230
[TBL] [Abstract][Full Text] [Related]
16. Transarterial Chemoembolization and (90)Y Radioembolization for Hepatocellular Carcinoma: Review of Current Applications Beyond Intermediate-Stage Disease.
Fidelman N; Kerlan RK
AJR Am J Roentgenol; 2015 Oct; 205(4):742-52. PubMed ID: 26397322
[TBL] [Abstract][Full Text] [Related]
17. Comparison of transcatheter arterial chemoembolization and microsphere embolization for treatment of unresectable hepatocellular carcinoma: a meta-analysis.
Xie F; Zang J; Guo X; Xu F; Shen R; Yan L; Yang J; He J
J Cancer Res Clin Oncol; 2012 Mar; 138(3):455-62. PubMed ID: 22179199
[TBL] [Abstract][Full Text] [Related]
18. Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma.
Kallini JR; Gabr A; Salem R; Lewandowski RJ
Adv Ther; 2016 May; 33(5):699-714. PubMed ID: 27039186
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of transarterial interventional therapy for treatment of hepatocellular carcinoma with peritoneal metastases.
Duan F; Bai Y; Cui L; Li X; Yan J
J Cancer Res Ther; 2018; 14(7):1563-1566. PubMed ID: 30589039
[TBL] [Abstract][Full Text] [Related]
20. Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone.
Brown KT; Do RK; Gonen M; Covey AM; Getrajdman GI; Sofocleous CT; Jarnagin WR; D'Angelica MI; Allen PJ; Erinjeri JP; Brody LA; O'Neill GP; Johnson KN; Garcia AR; Beattie C; Zhao B; Solomon SB; Schwartz LH; DeMatteo R; Abou-Alfa GK
J Clin Oncol; 2016 Jun; 34(17):2046-53. PubMed ID: 26834067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
